The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

@article{Gerber2008TheIO,
  title={The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.},
  author={David E. Gerber and J Bradley Segal and Moshe Yair Levy and Joyce M Kane and Richard M. Jones and Michael B. Streiff},
  journal={Blood},
  year={2008},
  volume={112 3},
  pages={504-10}
}
Venous thromboembolism (VTE) is increasingly diagnosed among individuals with hematologic malignancies. However, the risk of VTE among patients undergoing hematopoietic stem cell transplantation (HSCT) is unclear. We examined the incidence and risk factors for VTE and bleeding among 1514 patients undergoing in-patient HSCT. No protocolized VTE prophylaxis was used. By HSCT day 180, 75 symptomatic VTE occurred in 70 patients (4.6%; 95% confidence interval [CI], 3.6%-5.8%). Fifty-five (3.6%) were… CONTINUE READING
34 Citations
43 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Venous thromboembolism among 1,570 patients undergoing hematopoietic stem cell transplantation: incidence, risk factors, treatment and outcomes [abstract

  • DE Gerber, JB Segal, MY Levy, JM Kane, RJ Jones, MB. Streiff
  • GERBER et al BLOOD,
  • 2008

patients

  • DE Gerber, JB Segal, MY Levy, JM Kane, RJ Jones, MB Streiff
  • 2007

Similar Papers

Loading similar papers…